Safety and Efficacy of Glucagon-like Peptide 1 Receptor Agonists in Patients With Cirrhosis

被引：5
|
作者：
Morris, Sean M. [1 ]
Armstrong, Matthew J. [1 ,2 ]
Newsome, Philip N. [1 ,2 ]
机构：
[1] Univ Birmingham, Inst Immunol & Immunotherapy, Ctr Liver & Gastrointestinal Res, Birmingham, W Midlands, England
[2] Univ Birmingham, Univ Hosp Birmingham NHS Fdn Trust, Biomed Res Ctr, Natl Inst Hlth Res, Birmingham, W Midlands, England
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2022年 / 20卷 / 06期
关键词：
D O I：
10.1016/j.cgh.2021.09.023
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1220 / 1222
页数：3
相关论文
共 50 条
  • [1] The efficacy of Glucagon-like Peptide-1 receptor agonists in patients with compensated cirrhosis and obesity
    Ng, Wee Han
    Yeo, Yee Hui
    Singal, Amit
    Parikh, Neehar D.
    Kuo, Alexander
    Kim, Hyunseok
    Wang, Yun
    Trivedi, Hirsch
    Rich, Nicole
    Samaan, Jamil
    Ayoub, Walid S.
    Ma, Kevin
    Yang, Ju Dong
    JOURNAL OF HEPATOLOGY, 2024, 80 : S200 - S200
  • [2] Glucagon-Like Peptide-1 Receptor Agonists: Best Choice for Patients With Cirrhosis and Diabetes?
    Li, Yuanyuan
    Wang, Xiaoze
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (05) : 1142 - 1143
  • [3] Glucagon-Like Peptide-1 Receptor Agonists in Patients With Cirrhosis: Answering the Unanswered Questions?
    Mahgoub, Sara
    Newsome, Philip N.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (06) : 1186 - 1187
  • [4] Glucagon-Like Peptide-1 Receptor Agonists: Best Choice for Patients With Cirrhosis and Diabetes?
    Li, Yuanyuan
    Wang, Xiaoze
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (04) : 1142 - 1143
  • [5] Glucagon-Like Peptide-1 Receptor Agonists
    Edelman, Steven V.
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (10): : S12 - S16
  • [6] Glucagon-Like Peptide 1 Receptor Agonists in Psychiatry
    Himmerich, Hubertus
    Mcelroy, Susan L.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2024, 44 (03) : 207 - 210
  • [7] Glucagon-like peptide-1 receptor agonists and safety in the preconception period
    Minis, Evelyn
    Stanford, Fatima Cody
    Mahalingaiah, Shruthi
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2023, 30 (06) : 273 - 279
  • [8] Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Solid Organ Transplant.
    Sweiss, H.
    Zeilmann, D.
    Escamilla, J.
    Hall, R.
    Bhayana, S.
    Patel, R.
    Long, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1073 - 1073
  • [9] Glucagon-Like Peptide-1 Receptor Agonists and Hepatic Decompensation Events in Patients With Cirrhosis and Diabetes
    Simon, Tracey G.
    Patorno, Elisabetta
    Schneeweiss, Sebastian
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (06) : 1382 - +
  • [10] Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes
    De Block, Christophe E. M.
    Dirinck, Eveline
    Verhaegen, Ann
    Van Gaal, Luc F.
    DIABETES OBESITY & METABOLISM, 2022, 24 (05): : 788 - 805
12345